Updated:
Innovitech
Montreal-based venture capital firm Innovitech invests in early-stage and growth-stage technology companies across seed, startup, and growth equity stages.
Innovitech
Innovitech is a venture capital firm headquartered in Montreal, Quebec. The firm targets early-stage and growth-stage technology companies, with a stated strategy encompassing seed, startup, and growth equity allocations. As a Canadian private equity entity, Innovitech operates within a venture ecosystem shaped by provincial tax incentives and federal R&D credits, though the firm’s own structure, founding date, and leadership team are not publicly disclosed. The firm’s investment approach spans multiple stages, suggesting a flexible mandate that can back companies from initial formation through later funding rounds. Without confirmed portfolio companies or disclosed sector concentrations, the specific industry focuses of Innovitech remain general. The firm's geographic base in Montreal places it within a market known for AI research, aerospace engineering, and university spinouts from institutions like McGill and Université de Montréal, though no direct institutional affiliations are verified. Information on Innovitech’s scale and personnel is limited. The firm does not publicly report assets under management, total deployment figures, or team headcount. No additional offices, philanthropic entities, or adjacent operating vehicles are confirmed. Recent operational events — including fund closes, promotions, or new platform launches — are not captured in the public record as of the latest review. Innovitech’s structural differentiator lies in its independence. The firm operates without the tethers of a corporate parent, sovereign mandate, or single-family wealth origin common among hybrid or institutionally-anchored Canadian VCs. This independence may afford it a sourcing model reliant on founder networks and regional partnership dynamics, though the opacity of its portfolio and personnel prevents a fuller assessment of its competitive posture.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
Canada
City
Montreal
Corporate office
Montreal, Quebec, Canada
Frequently asked questions
What stages does Innovitech invest in?
Innovitech’s strategy covers seed, startup, and growth stages, indicating a mandate that can support portfolio companies from early formation through later-stage funding rounds. The firm does not specify check-size ranges or reserve allocation policies for follow-on investments. Without confirmed portfolio companies, the degree to which it leans toward seed versus growth in practice is not publicly verifiable.
Who leads investment decisions at Innovitech?
Innovitech does not publicly disclose its investment committee structure, managing partners, or senior investment professionals. This absence of named leadership is uncommon among Canadian venture firms with an active web presence. No public filings or third-party profiles identify the individuals responsible for sourcing, diligence, or portfolio management.
Is Innovitech affiliated with any corporate, university, or government entity?
No corporate parent, endowment, government agency, or university affiliation is publicly disclosed for Innovitech. The firm appears to operate as an independent asset manager rather than a strategic corporate venture arm. This independence distinguishes it from Montreal-based vehicles tied to pension funds like CDPQ or university-linked programs.
Which sectors does Innovitech target?
The firm describes its focus broadly as technology investing, without specifying vertical concentrations such as artificial intelligence, enterprise software, or healthtech. Montreal’s venture market has notable strengths in AI and aerospace, but no evidence ties Innovitech to these clusters. Sectors explicitly avoided are also not disclosed.
Has Innovitech raised institutional fund commitments?
No fundraises, limited partner disclosures, or regulatory filings such as Form ADV are publicly available for Innovitech. The firm’s capital base — whether institutional, high-net-worth, or principal capital — is not stated. This opacity limits allocator assessment of the firm’s backing and governance structure.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: